Form 8-K - Current report:
SEC Accession No. 0001104659-25-104439
Filing Date
2025-10-30
Accepted
2025-10-30 16:46:02
Documents
15
Period of Report
2025-10-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2529606d1_8k.htm   iXBRL 8-K 39486
2 EXHIBIT 99.1 tm2529606d1_ex99-1.htm EX-99.1 12896
6 GRAPHIC tm2529606d1_ex99-1img01.jpg GRAPHIC 2466
7 GRAPHIC tm2529606d1_ex99-1img02.jpg GRAPHIC 2383
  Complete submission text file 0001104659-25-104439.txt   233311

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asrt-20251027.xsd EX-101.SCH 3020
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20251027_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20251027_pre.xml EX-101.PRE 22362
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2529606d1_8k_htm.xml XML 3681
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 251436629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)